These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 28434174)

  • 1. Molecular Alterations and Expression Dynamics of LATS1 and LATS2 Genes in Non-Small-Cell Lung Carcinoma.
    Malik SA; Khan MS; Dar M; Hussain MU; Shah MA; Shafi SM; Mudassar S
    Pathol Oncol Res; 2018 Apr; 24(2):207-214. PubMed ID: 28434174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers.
    Takahashi Y; Miyoshi Y; Takahata C; Irahara N; Taguchi T; Tamaki Y; Noguchi S
    Clin Cancer Res; 2005 Feb; 11(4):1380-5. PubMed ID: 15746036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LATS2 as a poor prognostic marker regulates non-small cell lung cancer invasion by modulating MMPs expression.
    Wu A; Li J; Wu K; Mo Y; Luo Y; Ye H; Mai Z; Guo K; Wang Y; Li S; Chen H; Luo W; Yang Z
    Biomed Pharmacother; 2016 Aug; 82():290-7. PubMed ID: 27470365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter hypermethylation-mediated down-regulation of LATS1 and LATS2 in human astrocytoma.
    Jiang Z; Li X; Hu J; Zhou W; Jiang Y; Li G; Lu D
    Neurosci Res; 2006 Dec; 56(4):450-8. PubMed ID: 17049657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TAZ is an independent prognostic factor in non-small cell lung carcinoma: Elucidation at protein level.
    Malik SA; Khan MS; Dar M; Hussain MU; Mudassar S
    Cancer Biomark; 2017; 18(4):389-395. PubMed ID: 28128737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of LATS1 contributes to good prognosis and can negatively regulate YAP oncoprotein in non-small-cell lung cancer.
    Lin XY; Zhang XP; Wu JH; Qiu XS; Wang EH
    Tumour Biol; 2014 Jul; 35(7):6435-43. PubMed ID: 24682895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of PAX6 by promoter methylation is associated with poor prognosis in non small cell lung cancer.
    Zhang X; Yang X; Wang J; Liang T; Gu Y; Yang D
    Int J Clin Exp Pathol; 2015; 8(9):11452-7. PubMed ID: 26617874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of LATS2 in non-small cell lung cancer promoted the growth and motility of cancer cells.
    Yao F; Liu H; Li Z; Zhong C; Fang W
    Tumour Biol; 2015 Mar; 36(3):2049-57. PubMed ID: 25391426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long Noncoding RNA PVT1 Promotes Non-Small Cell Lung Cancer Cell Proliferation through Epigenetically Regulating LATS2 Expression.
    Wan L; Sun M; Liu GJ; Wei CC; Zhang EB; Kong R; Xu TP; Huang MD; Wang ZX
    Mol Cancer Ther; 2016 May; 15(5):1082-94. PubMed ID: 26908628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells.
    Li W; Sun M; Zang C; Ma P; He J; Zhang M; Huang Z; Ding Y; Shu Y
    Cell Death Dis; 2016 May; 7(5):e2225. PubMed ID: 27195672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter Hypermethylation of LATS2 Gene in Oral Squamous Cell Carcinoma (OSCC) Among North Indian Population.
    Goel H; Singhal S; Mathur R; Syeda S; Gupta RK; Kumar A; Shrivastava A; Jha AK
    Asian Pac J Cancer Prev; 2020 May; 21(5):1283-1287. PubMed ID: 32458634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low expression of ITIH5 in adenocarcinoma of the lung is associated with unfavorable patients' outcome.
    Dötsch MM; Kloten V; Schlensog M; Heide T; Braunschweig T; Veeck J; Petersen I; Knüchel R; Dahl E
    Epigenetics; 2015; 10(10):903-12. PubMed ID: 26252352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients.
    Ghasemkhani N; Shadvar S; Masoudi Y; Talaei AJ; Yahaghi E; Goudarzi PK; Shakiba E
    Diagn Pathol; 2015 Sep; 10():164. PubMed ID: 26377406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LATS2 tumour specific mutations and down-regulation of the gene in non-small cell carcinoma.
    Strazisar M; Mlakar V; Glavac D
    Lung Cancer; 2009 Jun; 64(3):257-62. PubMed ID: 19008013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of the YAP1 oncogene in clear cell renal cell carcinoma is associated with poor outcome.
    Rybarczyk A; Klacz J; Wronska A; Matuszewski M; Kmiec Z; Wierzbicki PM
    Oncol Rep; 2017 Jul; 38(1):427-439. PubMed ID: 28504812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter Hypermethylation of Genes Encoding for RASSF/Hippo Pathway Members Reveals Specific Alteration Pattern in Diffuse Gliomas.
    Levallet G; Creveuil C; Bekaert L; Péres E; Planchard G; Lecot-Cotigny S; Guillamo JS; Emery E; Zalcman G; Lechapt-Zalcman E
    J Mol Diagn; 2019 Jul; 21(4):695-704. PubMed ID: 31055025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen receptor expression and gene promoter methylation in non-small cell lung cancer - a short report.
    Tekpli X; Skaug V; Bæra R; Phillips DH; Haugen A; Mollerup S
    Cell Oncol (Dordr); 2016 Dec; 39(6):583-589. PubMed ID: 27572263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypermethylation of promoter region of LATS1--a CDK interacting protein in oral squamous cell carcinomas--a pilot study in India.
    Reddy VR; Annamalai T; Narayanan V; Ramanathan A
    Asian Pac J Cancer Prev; 2015; 16(4):1599-603. PubMed ID: 25743838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pseudogene DUXAP10 promotes an aggressive phenotype through binding with LSD1 and repressing LATS2 and RRAD in non small cell lung cancer.
    Wei CC; Nie FQ; Jiang LL; Chen QN; Chen ZY; Chen X; Pan X; Liu ZL; Lu BB; Wang ZX
    Oncotarget; 2017 Jan; 8(3):5233-5246. PubMed ID: 28029651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer.
    Liu Y; Zhang G; Li H; Han L; Fu A; Zhang N; Zheng Y
    Biomed Pharmacother; 2015 Oct; 75():185-90. PubMed ID: 26337230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.